THERAGENICS CORP
TGX
TGX was delisted on the 29th of October, 2013.
41 hedge funds and large institutions have $32.3M invested in THERAGENICS CORP in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
30% more capital invested
Capital invested by funds: $24.9M → $32.3M (+$7.43M)
21% more funds holding
Funds holding: 34 → 41 (+7)
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
+$3.11M |
| 2 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$1.83M |
| 3 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$891K |
| 4 |
LOM
Loeb Offshore Management
New York
|
+$839K |
| 5 |
Renaissance Technologies
New York
|
+$259K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
-$783K |
| 2 |
AG
Algert Global
San Francisco,
California
|
-$186K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$149K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$119K |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$66K |
TGX Hedge Fund Activity: Q3 2013 in Review
41 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in THERAGENICS CORP (TGX) for Q3 2013, worth a combined $32.3M — up 30% from $24.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TGX positions and 2 closed out — a net gain of 7 holders — while 6 added to existing stakes and 14 trimmed.
The largest buyer was Longfellow Investment Management, opening a new position worth an estimated $3.11M. The largest seller was Cannell Capital, cutting an estimated $783K.
- 41 institutional investors held THERAGENICS CORP (TGX) as of Q3 2013, up from 34 in Q2 2013.
- Funds reported $32.3M of THERAGENICS CORP stock for Q3 2013, up 30% quarter-over-quarter.
- 9 funds opened new THERAGENICS CORP positions in Q3 2013 and 2 closed out, a net change of +7 holders.
- The largest THERAGENICS CORP buyer in Q3 2013 was Longfellow Investment Management, an estimated $3.11M added.
- The largest THERAGENICS CORP seller in Q3 2013 was Cannell Capital, an estimated $783K sold.
Based on aggregated 13F filings for Q3 2013.